Protective Ostomies in Ovarian Cancer Surgery: a Systematic Review and Meta-analysis

Overview

Journal J Gynecol Oncol

Specialties Gynecology & Obstetrics
Oncology

Date 2022 Mar 4

PMID 35245000

Authors

Beatriz Navarro Santana

Esmeralda Garcia Torralba

Jose Verdu Soriano

Maria Laseca

Alicia Martin Martinez

Affiliations

Soon will be listed here.

Abstract

Objective: To assess the benefit of protective ostomies on anastomotic leak rate, urgent re-operations, and mortality due to anastomotic leak complications in ovarian cancer surgery.

Methods: A systematic literature search was performed in MEDLINE, Web of Science, ClinicalTrials.gov, and the Cochrane Central Register of Controlled Trials for all studies on anastomotic leak and ostomy formation related to ovarian cancer surgery. Non-controlled studies, case series, abstracts, case reports, study protocols, and letters to the editor were excluded. Meta-analysis was performed on the primary endpoint of anastomotic leak rate. Subgroup analysis was carried out based on type of bowel resection and bevacizumab use. Secondary endpoints were urgent re-operations and mortality associated with anastomotic leak, length of hospital stay, postoperative complications, 30-day readmission rate, adjuvant chemotherapy, survival, and reversal surgery in ostomy and non-ostomy patients.

Results: A total of 17 studies (2,719 patients) were included: 16 retrospective cohort studies, and 1 case-control study. Meta-analysis of 17 studies did not show a decrease in anastomotic leak rate in ostomy patients (odds ratio [OR]=1.01; 95% confidence interval [CI]=0.60-1.70; p=0.980). Meta-analysis of ten studies (1,452 women) did not find a decrease in urgent re-operations in the ostomy group (OR=0.72; 95% CI=0.35-1.46; p=0.360). Other outcomes were not considered for meta-analysis due to the lack of data in included studies.

Conclusion: Protective ostomies did not decrease anastomotic leak rates, and urgent re-operations in ovarian cancer surgery. This evidence supports the use of ostomies in very select cases.

Citing Articles

Determining the effect of frailty on survival in advanced ovarian cancer: study protocol for a prospective multicentre national cohort study (FOLERO).

Hunde D, Ekerstad N, Asp M, Kannisto P, Wedin M, Palmqvist C Acta Oncol. 2025; 64:208-213.

PMID: 39907536 PMC: 11816292. DOI: 10.2340/1651-226X.2025.42292.

Surgical management of anastomotic leakage related to ovarian cancer surgery: a narrative review.

Restaino S, Schierano S, Arcieri M, Costantini B, Poli A, Pregnolato S Front Surg. 2024; 11:1434730.

PMID: 39323910 PMC: 11422216. DOI: 10.3389/fsurg.2024.1434730.

Anastomotic Leak in Ovarian Cancer Cytoreduction Surgery: A Systematic Review and Meta-Analysis.

Fornasiero M, Geropoulos G, Kechagias K, Psarras K, Katsikas Triantafyllidis K, Giannos P Cancers (Basel). 2022; 14(21).

PMID: 36358882 PMC: 9653973. DOI: 10.3390/cancers14215464.

References

Pakkastie T, Luukkonen P, Jarvinen H . Anastomotic leakage after anterior resection of the rectum. Eur J Surg. 1994; 160(5):293-7; discussion 299-300. View

Montedori A, Cirocchi R, Farinella E, Sciannameo F, Abraha I . Covering ileo- or colostomy in anterior resection for rectal carcinoma. Cochrane Database Syst Rev. 2010; (5):CD006878. DOI: 10.1002/14651858.CD006878.pub2. View

Bridges J, Leung Y, Hammond I, McCartney A . En bloc resection of epithelial ovarian tumors with concomitant rectosigmoid colectomy: the KEMH experience. Int J Gynecol Cancer. 1993; 3(4):199-202. DOI: 10.1046/j.1525-1438.1993.03040199.x. View

Siegel R, Miller K, Jemal A . Cancer statistics, 2019. CA Cancer J Clin. 2019; 69(1):7-34. DOI: 10.3322/caac.21551. View

Fournier M, Huchon C, Ngo C, Bensaid C, Bats A, Combe P . Morbidity of rectosigmoid resection in cytoreductive surgery for ovarian cancer. Risk factor analysis. Eur J Surg Oncol. 2018; 44(6):750-753. DOI: 10.1016/j.ejso.2018.01.005. View

Richardson D, Mariani A, Cliby W . Risk factors for anastomotic leak after recto-sigmoid resection for ovarian cancer. Gynecol Oncol. 2006; 103(2):667-72. DOI: 10.1016/j.ygyno.2006.05.003. View

Song Y, Lim M, Kang S, Seo S, Park J, Choi H . Total colectomy as part of primary cytoreductive surgery in advanced Müllerian cancer. Gynecol Oncol. 2009; 114(2):183-7. DOI: 10.1016/j.ygyno.2009.04.009. View

Mourton S, Temple L, Abu-Rustum N, Gemignani M, Sonoda Y, Bochner B . Morbidity of rectosigmoid resection and primary anastomosis in patients undergoing primary cytoreductive surgery for advanced epithelial ovarian cancer. Gynecol Oncol. 2005; 99(3):608-14. DOI: 10.1016/j.ygyno.2005.07.112. View

Grabham J, Moran B, Lane R . Defunctioning colostomy for low anterior resection: a selective approach. Br J Surg. 1995; 82(10):1331-2. DOI: 10.1002/bjs.1800821011. View

10.

Tozzi R, Casarin J, Garruto-Campanile R, Soleymani Majd H, Morotti M . Morbidity and reversal rate of ileostomy after bowel resection during Visceral-Peritoneal Debulking (VPD) in patients with stage IIIC-IV ovarian cancer. Gynecol Oncol. 2017; 148(1):74-78. DOI: 10.1016/j.ygyno.2017.11.017. View

11.

Bartl T, Schwameis R, Stift A, Bachleitner-Hofmann T, Reinthaller A, Grimm C . Predictive and Prognostic Implication of Bowel Resections During Primary Cytoreductive Surgery in Advanced Epithelial Ovarian Cancer. Int J Gynecol Cancer. 2018; 28(9):1664-1671. DOI: 10.1097/IGC.0000000000001369. View

12.

Kalogera E, Dowdy S, Mariani A, Weaver A, Aletti G, Bakkum-Gamez J . Multiple large bowel resections: potential risk factor for anastomotic leak. Gynecol Oncol. 2013; 130(1):213-8. PMC: 3686884. DOI: 10.1016/j.ygyno.2013.04.002. View

13.

Bristow R, Tomacruz R, Armstrong D, Trimble E, Montz F . Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol. 2002; 20(5):1248-59. DOI: 10.1200/JCO.2002.20.5.1248. View

14.

Chen J, Wang D, Yu H, Zhao Z, Wang L, Li Y . Defunctioning stoma in low anterior resection for rectal cancer: a meta- analysis of five recent studies. Hepatogastroenterology. 2011; 59(118):1828-31. DOI: 10.5754/hge11786. View

15.

Jurado M, Alcazar J, Baixauli J, Hernandez-Lizoain J . Low colorectal anastomosis after pelvic exenteration for gynecologic malignancies: risk factors analysis for leakage. Int J Gynecol Cancer. 2011; 21(2):397-402. DOI: 10.1097/IGC.0b013e31820b2df7. View

16.

Eckmann C, Kujath P, Schiedeck T, Shekarriz H, Bruch H . Anastomotic leakage following low anterior resection: results of a standardized diagnostic and therapeutic approach. Int J Colorectal Dis. 2004; 19(2):128-33. DOI: 10.1007/s00384-003-0498-8. View

17.

Burger R, Monk B, McMeekin D, Vasilev S, Disaia P, Kohler M . Bowel resection at the time of primary cytoreduction for epithelial ovarian cancer. J Am Coll Surg. 2002; 193(6):626-32. DOI: 10.1016/s1072-7515(01)01090-0. View

18.

Tseng J, Suidan R, Zivanovic O, Gardner G, Sonoda Y, Levine D . Diverting ileostomy during primary debulking surgery for ovarian cancer: Associated factors and postoperative outcomes. Gynecol Oncol. 2016; 142(2):217-24. PMC: 4961543. DOI: 10.1016/j.ygyno.2016.05.035. View

19.

Tan W, Tang C, Shi L, Eu K . Meta-analysis of defunctioning stomas in low anterior resection for rectal cancer. Br J Surg. 2009; 96(5):462-72. DOI: 10.1002/bjs.6594. View

20.

Moutardier V, Houvenaeghel G, Lelong B, Mokart D, Delpero J . Colorectal function preservation in posterior and total supralevator exenteration for gynecologic malignancies: an 89-patient series. Gynecol Oncol. 2003; 89(1):155-9. DOI: 10.1016/s0090-8258(03)00069-6. View